Theme:

Promote the Linkage between Social Capital and Pharmaceutical Innovation, Improve Innovation Capability of Pharmaceutical Industry

Time: October 29-31, 2017

Venue: Suzhou Jinji Lake International Convention Center

(Add: 688 East Suzhou Avenue, Suzhou Industrial Park, Suzhou, Jiangsu Province)

Hosts:

ŸSecurity Association of China (SAC)

ŸChina Pharmaceutical Innovation and Research Development Association (PhIRDA)

ŸChina Association for Medical Devices Industry (CAMDI)

Participants:

Ÿ400+ pharmaceutical companies and medical device companies

Ÿ300+ investment institutions

Ÿ2000+ attendees

ŸEmbassies in China from different countries & International pharmaceutical industry organizations

Highlights of the Conference

1. Overall Designed and co-hosted by the Pharmaceutical Innovation Industry and Investment Community

2017 China BioMed Innovation and Investment Conference is co-hosted by Security Association of China (SAC), China Pharmaceutical Innovation and Research Development Association (PhIRDA) and China Association for Medical Devices Industry (CAMDI). Fully relying on the strength of members in the fields of pharmaceutical research and development and investment, SAC, PhIRDA and CAMDI bring together the leading experts of the advanced pharmaceutical research institutions, innovative companies and investment institutions as the organizing committee, and make preparation to secure the orderly promotion of the conference.

2. Strong attention from industry and support from international famous investment bank, publication and media.

J. P. Chase & Co. (J. P. Morgan) and world famous top journal Nature will support this event. The conference will invite domestic authoritative media to cover this event.

3. Dialogue between leaders from related government authorities, scholars and experts domestic and abroad

The opening ceremony is on the morning of October 29, leaders from related government authorities, scholars and experts domestic and abroad,

KOLs from investment institutions and pharmaceutical industry will be invited to make remarks or to give keynote speeches.

4. Worldwide Participation

2017 China BioMed Innovation and Investment Conference will gather more than 400 pharmaceutical companies, medical device companies and R & D institutions, more than 300 investment institutions. Moreover, embassies in China from different countries and international industry organizations will send representative to participate in this event as well. The total number of participants is expected to exceed 2000. Negotiation areas will be provided to the attendees for further discussion on collaboration.

5. Held Clinical-Trial Data Release of Innovative Drugs

The conference will specifically arrange the Clinical-Trial Data Release of Innovative Drugs after the opening ceremony. Top leading pharmaceutical innovative projects will be released in this session, which is helpful for the investment community to rapidly and accurately know the latest developments of the research and development of innovative drugs in pharmaceutical industry, so as to grasp the best investment opportunity. It will also promote the social capital to be invested in pharmaceutical innovation in an early stage.